Vaginal Infection Study 2

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lumara Health, Inc.
• Treatments: Butoconazole; Clindamycin; Clindamycin palmitate; Clindamycin phosphate

Criteria

Inclusion Criteria:

• Patients must have a clinical diagnosis of vaginal infection.

• Patients must be post-menopausal, surgically sterilized or using an acceptable form of birth control.

Exclusion Criteria:

• Patients must not have any other infections

• May not be pregnant or nursing

• May not be receiving any other antimicrobial therapies or any medications that would interfere with the outcome of the study.